当前位置:
首页
网刊
药物性肝损伤生物标志物研究进展
药物性肝损伤生物标志物研究进展
刘小茜,吴文晓,耿兴超,李 波

中国食品药品检定研究院国家药物安全评价监测中心,药物非临床安全评价研究北京市重点实验室,北京 100176
Research progress of biomarkers of drug-induced liver injury
(Beijing Key Laboratory, National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing 100176, China)

摘要参考文献相关文章

起始页:47

摘要:[摘要] 药物性肝损伤(drug-induced liver injury,DILI)是药物不良反应和药物撤市或限制使用的主要原因。生物标志物检测是临床前药物肝毒性评价和临床患者潜在肝损伤诊断的重要技术手段。随着组学技术的快速发展和肝损伤机制研究的不断深入,关于新型DILI生物标志物研究报道也越来越多。本文综述了近年来国内外DILI生物标志物研究的最新进展,以期为更好地评价药物潜在的肝毒性风险提供参考,为临床肝损伤诊断提供依据。

关键词:[关键词] 药物性肝损伤;生物标志物;组学技术;肝损伤机制

通讯作者:

基金项目:

作者简介:

Abstract:[Abstract] Drug-induced liver injury (DILI) is the main cause of adverse drug reactions, and drug withdrawal or restrictions. Biomarkers are important tools for evaluating preclinical drug hepatotoxicity and clinical diagnosis of potential liver injury in patients. In recent years, with the rapid development of omics technology and the development of mechanism research of of liver injury, there were more and more reports on new DILI biomarkers. In this paper, recent advances in the research of DILI biomarkers at home and abroad were reviewed, which could provide references for better evaluation of the potential risk of hepatotoxicity and clinical diagnosis of liver injury.

Key words:[Key words] drug-induced liver injury; biomarker; omics technology; mechanism of liver injury

    [1] GAO Y, CAO Z, YANG X, et al. Proteomic analysis of acetaminophen-induced hepatotoxicity and identification of heme oxygenase 1 as a potential plasma biomarker of liver injury[J]. Proteomics Clin Appl, 2017, 11(1-2). Epud 2016 Oct 28.
    [2] KEMELO MK, KUTINOV CANOV N, HORINEK A, et al. Sirtuin-activating compounds (STACs) alleviate D-galactosamine/lipopolysaccharide-induced hepatotoxicity in rats: involvement of sirtuin 1 and heme oxygenase 1[J]. Physiol Res, 2017, 66(3): 497-505.
    [3] PRIMA V, CAO M, SVETLOV S. ASS and SULT2A1 are novel and sensitive biomarkers of acute hepatic injury-a comparative study in animal models[J]. J Liver, 2013, 2(1): pii: 1000115.
    [4] QIN S, ZHOU Y, GRAY L, et al. Identification of organ-enriched protein biomarkers of acute liver injury by targeted quantitative proteomics of blood in acetaminophen- and carbon-tetrachloride-treated mouse models and acetaminophen overdose patients[J]. J Proteome Res, 2016, 15(10): 3724-3740. 
    [5] MIKUS M, DROBIN K, GRY M, et al. Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury[J]. Liver Int, 2017, 37(1): 132-140. 
    [6] BAILEY WJ, HOLDER D, PATEL H, et al. A performance evaluation of three drug-induced liver injury biomarkers in the rat: alpha-glutathione S-transferase, arginase 1, and 4-hydroxyphenyl-pyruvate dioxygenase[J]. Toxicol Sci, 2012, 130(2): 229-244. 
    [7] IRUZUBIETA P, ARIAS-LOSTE MT, BARBIER-TORRES L, et al. The need for biomarkers in diagnosis and prognosis of drug-induced liver disease: does metabolomics have any role?[J]. Biomed Res Int, 2015, 2015,386186.
    [8] YAMAZAKI M, MIYAKE M, SATO H, et al. Perturbation of bile acid homeostasis is an early pathogenesis event of drug induced liver injury in rats[J]. Toxicol Appl Pharmacol, 2013, 268(1): 79-89. 
    [9] LUO L, SCHOMAKER S, HOULE C, et al. Evaluation of serum bile acid profiles as biomarkers of liver injury in rodents[J]. Toxicol Sci, 2014, 137(1): 12-25. 
    [10] DONATO MT, LPEZ-RIERA M, CASTELL JV, et al. Both cholestatic and steatotic drugs trigger extensive alterations in the mRNA level of biliary transporters in rat hepatocytes: application to develop new predictive biomarkers for early drug development[J]. Toxicol Lett, 2016, 263: 58-67.
    [11] STARKEY LEWIS PJ, MERZ M, COUTTET P, et al. Serum microRNA biomarkers for drug-induced liver injury[J]. Clin Pharmacol Ther, 2012, 92(3): 291-293. 
    [12] WANG K, ZHANG S, MARZOLF B, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury[J]. Proc Natl Acad Sci U S A, 2009, 106(11): 4402-4407. 
    [13] STARCKX S, BATHEJA A, VERHEYEN GR, et al. Evaluation of miR-122 and other biomarkers in distinct acute liver injury in rats[J]. Toxicol Pathol, 2013, 41(5): 795-804. 
    [14] WOLENSKI FS, SHAH P, SANO T, et al. Identification of microRNA biomarker candidates in urine and plasma from rats with kidney or liver damage[J]. J Appl Toxicol, 2017, 37(3): 278-286. 
    [15] CHURCH RJ, OTIENO M, MCDUFFIE JE, et al. Beyond miR-122: Identification of microRNA alterations in blood during a time course of hepatobiliary injury and biliary hyperplasia in rats[J]. Toxicol Sci, 2016, 150(1): 3-14.
    [16] CHO H, KIM H, NA D, et al. Meta-analysis method for discovering reliable biomarkers by integrating statistical and biological approaches: an application to liver toxicity[J]. Biochem Biophys Res Commun, 2016, 471(2): 274-281.
    [17] YANO A, ODA S, FUKAMI T, et al. Development of a cell-based assay system considering drug metabolism and immune- and inflammatory-related factors for the risk assessment of drug-induced liver injury[J]. Toxicol Lett, 2014, 228(1): 13-24.
    [18] ODA S, MATSUO K, NAKAJIMA A, et al. A novel cell-based assay for the evaluation of immune- and inflammatory-related gene expression as biomarkers for the risk assessment of drug-induced liver injury[J]. Toxicol Lett, 2016, 241: 60-70. 
    [19] BUNESS A, ROTH A, HERRMANN A, et al. Identification of metabolites, clinical chemistry markers and transcripts associated with hepatotoxicity[J]. PLoS One, 2014, 9(5): e97249. 
    [20] DERDAK Z, VILLEGAS KA, WANDS JR, et al. Early growth response-1 transcription factor promotes hepatic fibrosis and steatosis in long-term ethanol-fed Long-Evans rats[J]. Liver Int, 2012, 32(5): 761-770. 
    [21] LI HH, DOIRON K, PATTERSON AD, et al. Identification of serum insulin-like growth factor binding protein 1 as diagnostic biomarker for early-stage alcohol-induced liver disease[J]. J Transl Med, 2013,11: 266.
    [22] FURUYA S,KONO H, HARA M, et al. Interleukin 17A plays a role in lipopolysaccharide/D-galactosamine-induced fulminant hepatic injury in mice[J]. Surg Res, 2015, 199(2): 487-493.
    [23] YANO A, HIGUCHI S, TSUNEYAMA K, et al. Involvement of immune-related factors in diclofenac-induced acute liver injury in mice[J]. Toxicology, 2012, 293(1-3): 107-114. 
    [24] LIAO CC, DAY YJ, LEE HC, et al. Baicalin attenuates IL-17-mediated acetaminophen-induced liver injury in a mouse model[J]. PLoS One, 2016, 11(11): e0166856. 
    [25] KAKISAKA K, TAKIKAWA Y. Elevation of serum cytokines preceding elevation of liver enzymes in a case of drug-induced liver injury[J]. Hepatol Res, 2014, 44(10): E284-289. 
    [26] YAMAN H, CAKIR E, AKGUL EO, et al. Pentraxin 3 as a potential biomarker of acetaminophen-induced liver injury[J]. Exp Toxicol Pathol, 2013, 65(1-2): 147-151. 
    [27] MCGILL MR, LI F, SHARPE MR, et al. Circulating acylcarnitines as biomarkers of mitochondrial dysfunction after acetaminophen overdose in mice and humans[J]. Arch Toxicol, 2014, 88(2): 391-401.
    [28] BHATTACHARYYA S, YAN K, PENCE L, et al. Targeted liquid chromatography-mass spectrometry analysis of serum acylcarnitines in acetaminophen toxicity in children[J]. Biomark Med, 2014,8(2): 147-159.
    [29] SENTELLAS S, MORALES O, ZANUY M, et al. GSSG/GSH ratios in cryopreserved rat and human hepatocytes as a biomarker for drug induced oxidative stress[J]. Toxicol In Vitro, 2014, 28(5): 1006-1015. 
    [30] ZHANG HX, LIU SJ, TANG XL, et al. H2S Attenuates LPS-induced acute lung injury by reducing oxidative/nitrative stress and Inflammation[J]. Cell Physiol Biochem, 2016, 40(6): 1603-1612.
    [31] TEPPNER M, BSS F, ERNST B, et al. Application of lipid peroxidation products as biomarkers for flutamide-induced oxidative stress in vitro[J]. Toxicol Lett, 2015, 238(3): 53-59.